Please try another search
The sub-fund is an equity fund. The investment objective of the sub-fund is to achieve long-term capital growth by investing at least two thirds of the net assets of the fund in a portfolio of carefully chosen shares and other equity securities of companies in the healthcare sector taking account of sustainability criteria. The fund can also invest in companies whose main activity involves holding investments in such companies or financing such companies and that have their registered office or carry out the majority of their economic activity in recognised countries. Without limiting the scope of “healthcare sector”, the healthcare sector includes companies from the areas of pharmaceuticals, medical technology, biotechnology and related sectors.
Name | Title | Since | Until |
---|---|---|---|
Samuel Stursberg | - | 2018 | Now |
Biography | Since 2015 Head Research Health Care Funds & Mandates; 2007-2014 Head Research at Adamant Biomedical Investment AG; 2005-2007 Stock analysis medtech and biotech at Bank Sarasin; 2001-2005 Sustainable Asset Management, stock analysis in healthcare; M.Sc University of Basel, MBA HSG, CFA | ||
Zahide Donat | - | 2018 | Now |
Biography | Since2015 Junior Portfolio Manager; 2014-2015 Credit Suisse AG, Banking Operations Specialist in Fixed Income; 2010-2013 Migros Bank AG, Relationship Manager; Bachelor of Science ZFH in Business Administration (Focus Banking and Finance) |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review